InNexus Biotechnology (InNexus Biotechnology) Days Payable : 0.00 (As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Days Payable?

InNexus Biotechnology's average Accounts Payable for the three months ended in Mar. 2011 was $1.93 Mil. InNexus Biotechnology's Cost of Goods Sold for the three months ended in Mar. 2011 was $0.00 Mil.

The historical rank and industry rank for InNexus Biotechnology's Days Payable or its related term are showing as below:

IXSBF's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.78
* Ranked among companies with meaningful Days Payable only.

InNexus Biotechnology's Days Payable stayed the same from Mar. 2010 (0.00) to Mar. 2011 (0.00). stayed the same

InNexus Biotechnology Days Payable Historical Data

The historical data trend for InNexus Biotechnology's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Days Payable Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

Days Payable

Get a 7-Day Free Trial

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of InNexus Biotechnology's Days Payable

For the Biotechnology subindustry, InNexus Biotechnology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InNexus Biotechnology's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InNexus Biotechnology's Days Payable distribution charts can be found below:

* The bar in red indicates where InNexus Biotechnology's Days Payable falls into.

InNexus Biotechnology Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

InNexus Biotechnology's Days Payable for the fiscal year that ended in Jun. 2010 is calculated as

	Days Payable (A: Jun. 2010 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2009 )	+	Accounts Payable (A: Jun. 2010 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2010 )	*	Days in Period
=	( (2.023	+	2.042)	/	2 )	/	0	*	365
=	2.0325					/	0	*	365
=	N/A

InNexus Biotechnology's Days Payable for the quarter that ended in Mar. 2011 is calculated as:

	Days Payable (Q: Mar. 2011 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2010 )	+	Accounts Payable (Q: Mar. 2011 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2011 )	*	Days in Period
=	( (1.889	+	1.973)	/	2 )	/	0	*	365 / 4
=	1.931					/	0	*	365 / 4
=	N/A

InNexus Biotechnology Days Payable Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines